These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 17341527)
61. Experience with linezolid therapy in children with osteoarticular infections. Chen CJ; Chiu CH; Lin TY; Lee ZL; Yang WE; Huang YC Pediatr Infect Dis J; 2007 Nov; 26(11):985-8. PubMed ID: 17984803 [TBL] [Abstract][Full Text] [Related]
62. Clinical characteristics of linezolid-resistant Staphylococcus aureus infections. Peeters MJ; Sarria JC Am J Med Sci; 2005 Aug; 330(2):102-4. PubMed ID: 16103790 [TBL] [Abstract][Full Text] [Related]
63. Comparative in vitro activity of ceftobiprole against staphylococci displaying normal and small-colony variant phenotypes. von Eiff C; Friedrich AW; Becker K; Peters G Antimicrob Agents Chemother; 2005 Oct; 49(10):4372-4. PubMed ID: 16189125 [TBL] [Abstract][Full Text] [Related]
64. Osteomyelitits due to linezolid-resistant Staphylococcus epidermidis. Benefield RJ; Hinde GK; Abolnik IZ Clin Infect Dis; 2012 Apr; 54(8):1216-7. PubMed ID: 22337821 [No Abstract] [Full Text] [Related]
65. First report in Spain of linezolid non-susceptibility in a clinical isolate of Staphylococcus haemolyticus. Tarazona RE; Padilla TP; Gómez JC; Sánchez JE; Hernandez MS Int J Antimicrob Agents; 2007 Sep; 30(3):277-8. PubMed ID: 17600688 [No Abstract] [Full Text] [Related]
66. Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia. Erlandson KM; Sun J; Iwen PC; Rupp ME Clin Infect Dis; 2008 Jan; 46(1):30-6. PubMed ID: 18171210 [TBL] [Abstract][Full Text] [Related]
67. A refractory case of community-acquired pneumonia. Schlaudecker JD J Fam Pract; 2009 Nov; 58(11):573-5. PubMed ID: 19891934 [No Abstract] [Full Text] [Related]
68. Distribution and antibiotic resistance of coagulase-negative staphylococci isolated from human nosocomial infections. Lenkei G; Belicza E; Sztroj T; Rédai I; Rozgonyi F J Chemother; 1989 Jul; 1(4 Suppl):277-9. PubMed ID: 16312400 [No Abstract] [Full Text] [Related]
69. Sequential linezolid-resistant Staphylococcus epidermidis isolates with G2576T mutation. Hong T; Li X; Wang J; Sloan C; Cicogna C J Clin Microbiol; 2007 Oct; 45(10):3277-80. PubMed ID: 17670931 [TBL] [Abstract][Full Text] [Related]
70. Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan. Huang YT; Hsiao CH; Liao CH; Lee CW; Hsueh PR J Clin Microbiol; 2008 Mar; 46(3):1132-6. PubMed ID: 18199793 [TBL] [Abstract][Full Text] [Related]
71. Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid? Mave V; Garcia-Diaz J; Islam T; Hasbun R J Antimicrob Chemother; 2009 Jul; 64(1):175-80. PubMed ID: 19423543 [TBL] [Abstract][Full Text] [Related]
72. Successful treatment of staphylococcal toxic shock syndrome with linezolid: a case report and in vitro evaluation of the production of toxic shock syndrome toxin type 1 in the presence of antibiotics. Stevens DL; Wallace RJ; Hamilton SM; Bryant AE Clin Infect Dis; 2006 Mar; 42(5):729-30. PubMed ID: 16447124 [No Abstract] [Full Text] [Related]
73. Coagulase-negative staphylococcal meningitis in adults: clinical characteristics and therapeutic outcomes. Huang CR; Lu CH; Wu JJ; Chang HW; Chien CC; Lei CB; Chang WN Infection; 2005 Apr; 33(2):56-60. PubMed ID: 15827871 [TBL] [Abstract][Full Text] [Related]
74. Time-dependent antibacterial effects of linezolid in experimental rabbit endocarditis. Buchanan LV; Dailey CF; LeMay RJ; Zielinski RJ; Kuo MS; Gibson JK J Antimicrob Chemother; 2002 Sep; 50(3):440-2. PubMed ID: 12205079 [No Abstract] [Full Text] [Related]
75. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05. Steinkraus G; White R; Friedrich L J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693 [TBL] [Abstract][Full Text] [Related]
76. In vitro activities of daptomycin, tigecycline, linezolid and eight other antibiotics, alone and in combination, against 41 Staphylococcus spp. clinical isolates from bone and joint infections. Kuli B; de Barbeyrac B; Dauchy FA; Dutronc H; Bébéar C; Mégraud F; Dupon M Int J Antimicrob Agents; 2009 May; 33(5):491-3. PubMed ID: 19153031 [No Abstract] [Full Text] [Related]
77. Anaerobic sepsis due to multidrug-resistant Bacteroides fragilis: microbiological cure and clinical response with linezolid therapy. Wareham DW; Wilks M; Ahmed D; Brazier JS; Millar M Clin Infect Dis; 2005 Apr; 40(7):e67-8. PubMed ID: 15824978 [TBL] [Abstract][Full Text] [Related]
78. Significance of Staphylococcus lugdunensis bacteremia: report of 28 cases and review of the literature. Zinkernagel AS; Zinkernagel MS; Elzi MV; Genoni M; Gubler J; Zbinden R; Mueller NJ Infection; 2008 Aug; 36(4):314-21. PubMed ID: 18648747 [TBL] [Abstract][Full Text] [Related]
79. Significance of coagulase negative staphylococci in neonates with late onset septicemia. Arora U; Jatwani J Indian J Pathol Microbiol; 2007 Jul; 50(3):680-1. PubMed ID: 17883185 [No Abstract] [Full Text] [Related]
80. Endocarditis due to vancomycin-resistant Enterococcus raffinosus successfully treated with linezolid: case report and review of literature. Jasovich A; Ganaha MC; Ebi C; García RD; Blanco MA; Lopardo H Rev Argent Microbiol; 2008; 40(4):204-7. PubMed ID: 19213241 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]